Language selection

Search

Details for: SANDOZ OLANZAPINE

Company: SANDOZ CANADA INCORPORATED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02310341SANDOZ OLANZAPINEOLANZAPINE2.5 MGTABLETORAL
02310368SANDOZ OLANZAPINEOLANZAPINE5.0 MGTABLETORAL
02327775SANDOZ OLANZAPINE ODTOLANZAPINE5 MGTABLET (ORALLY DISINTEGRATING)ORAL
02310376SANDOZ OLANZAPINEOLANZAPINE7.5 MGTABLETORAL
02327783SANDOZ OLANZAPINE ODTOLANZAPINE10 MGTABLET (ORALLY DISINTEGRATING)ORAL
02310384SANDOZ OLANZAPINEOLANZAPINE10.0 MGTABLETORAL
02310392SANDOZ OLANZAPINEOLANZAPINE15.0 MGTABLETORAL
02327791SANDOZ OLANZAPINE ODTOLANZAPINE15 MGTABLET (ORALLY DISINTEGRATING)ORAL
02327805SANDOZ OLANZAPINE ODTOLANZAPINE20 MGTABLET (ORALLY DISINTEGRATING)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: